Company news
Emyria Ltd news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Emyria receives $1,162,000 R&D Tax Incentive Refund
November 23, 2021
Emyria Welcomes Tattarang as Strategic Investor
November 21, 2021
MDMA Analogue Development Milestone
October 18, 2021
Emyria selected to join Palantirs Foundry Builders Program
October 6, 2021
Novel MDMA Analogue Screening Program Advanced
September 21, 2021
Emyria Expands Psychiatry Advisory for Psychedelics and MDMA
September 15, 2021
MDMA-analogues Show Promise for Parkinsons Disease
August 31, 2021
Emyria Engages Calvert Labs for Preclinical CBD studies
August 26, 2021
Emyria Appoints Expert Neuropharmacologist for MDMA Program
August 19, 2021
Emyria Executes Pure CBD Agreement with AltaSciences
August 12, 2021
Emyria to Develop Novel Psychedelics Pipeline with UWA
August 4, 2021
Emyria Advances EMD-004 Program Towards Registration
June 14, 2021
Emyria Data Validated, Care Model Reduces Opioids
June 6, 2021
Emyria Obtains TGA Approval for Medical Grade Monitoring App
May 12, 2021
Emyria and MMA launch MDMA-assisted therapy program for PTSD
May 4, 2021
$5m Placement for Drug Registration and Treatment Pipeline
April 21, 2021
Emyria and Cann Partner to Register CBD Product
March 28, 2021
Emyria Adds Second Clinical Site in Perth
March 1, 2021
Emyria adds second Emerald Clinic in Melbourne
February 9, 2021
Emyria wins digital health monitoring grant with UWA
February 4, 2021
FDA Position on RWE to Guide Registration
January 26, 2021
Emyria Pursuing Registration of EMD-003 in CY2021
January 4, 2021
Emyria to Benefit from Final TGA Ruling on CBD Medicines
December 15, 2020
Emyria Sees Strong Interest in IBS Study
December 3, 2020
Emyria Launches Drug Development Program Based on RWE
November 24, 2020
Emyria Partners with Thought Leaders in Psychedelic Therapy
November 18, 2020
Emyria Enters Data Deal with ZLD to Support Autism Trial
November 8, 2020
Webinar on Global Partnership with Sapphire Medical Clinics
October 21, 2020
Emyria Signs Real-World Data Agreement with Zelira
September 29, 2020
Preliminary Final Report and Full Year Statutory Accounts
August 31, 2020
Emerald Clinics Successfully Raises $2.2m in Placement
August 28, 2020
Record Appointments International Expansion and Name Change
August 13, 2020
Emerald Signs RWE Contract with Canopy Growth UK Company
August 9, 2020
EMDs Digital Health Platform Expands with New Technology
June 21, 2020
EMD Program Manager of National Clinical Data and Analytics
May 11, 2020
Decks
The 5 newest of 27 decks. Every deck is listed under its year.
- Q3 2026 Earnings Presentation
Earnings · 11 slides · Nov 2, 2026
- FY2026 Earnings Presentation
Earnings · 11 slides · Sep 8, 2026
- Investor Presentation (July 2026)
Investor deck · 22 slides · Jul 27, 2026
- Corporate Update (June 2026)
Corporate update · 24 slides · Jun 11, 2026
- Q1 2026 Earnings Presentation
Earnings · 13 slides · May 5, 2026